A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders (Q33371578)

26 July 2017

1 reference

title

A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

1 reference

1 reference

2

D Karpman

1 reference

26 July 2017

G Remuzzi

6

0 references

author name string

N Besbas

1

1 reference

26 July 2017

D Landau

3

1 reference

26 July 2017

C Loirat

4

1 reference

26 July 2017

W Proesmans

5

1 reference

26 July 2017

G Rizzoni

7

1 reference

26 July 2017

C M Taylor

8

1 reference

26 July 2017

N Van de Kar

9

1 reference

26 July 2017

L B Zimmerhackl

10

1 reference

26 July 2017

European Paediatric Research Group for HUS

11

1 reference

26 July 2017

language of work or name

English

0 references

publication date

14 June 2006

1 reference

26 July 2017

1 reference

26 July 2017

70

1 reference

26 July 2017

423-431

1 reference

26 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001581

26 July 2017

0 references

cites work

Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Risk factors for development of hemolytic uremic syndrome during shigellosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uraemic syndrome in a nursery school: green butter as the infection source

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Childhood hemolytic uremic syndrome, United Kingdom and Ireland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Prospective surveillance of Canadian children with the haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Invasive pneumococcal disease and hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Does red-cell T activation matter?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Factor H binds to washed human platelets.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Familial hemolytic uremic syndrome associated with complement factor H deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Familial haemolytic uraemic syndrome and an MCP mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The factor H protein family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The role of C5a in the development of thrombotic glomerulonephritis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic Microangiopathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Partial amino acid sequence of purified von Willebrand factor-cleaving protease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Localization of ADAMTS13 to the stellate cells of human liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura in a newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Cobalamin C defect associated with hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Cobalamin C deficiency complicated by an atypical glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Quinine sensitivity: a new cause of the hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Hemolytic uremic syndrome as a presenting form of HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients and sixty renal biopsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura associated with metastatic gastric adenocarcinoma: successful management with plasmapheresis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Hemolytic uremic syndrome in metastatic adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Carcinoma of the colon in a patient presenting with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Hemolytic uremic syndrome in a child with leukemia and cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Gemcitabine-associated thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Cyclosporine-associated thrombotic microangiopathy in renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

FK506-associated thrombotic microangiopathy: report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic microangiopathies associated with drugs and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic microangiopathy after renal transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Fulminant recurrence of atypical hemolytic uremic syndrome during a calcineurin inhibitor-free immunosuppression regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombocytopenic purpura and cardiomyopathy in pregnancy reversed by combined plasma exchange and infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura: medical and biological monitoring of six pregnancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

A 12-year-old girl with hemolytic uremic syndrome as initial symptom of systemic lupus erythematosus and a literature review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

A boy with acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Hemolytic uremic syndrome associated with glomerular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Haemolytic uraemic syndrome and idiopathic membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Hemolytic uremic syndrome associated with immunoglobulin A nephropathy: a case report and review of cases of hemolytic uremic syndrome with glomerular disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001581

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001581

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference